Albinism. Mayo Clinic. Accessed January 21, 2021. https://www.mayoclinic.org/diseases-conditions/albinism/symptoms-causes/syc-20369184
Baulier E, Garcia Diaz A, Corneo B, Farber DB. Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Research. 2018;33:274-277. doi:https://doi.org/10.1016/j.scr.2018.11.016
Boeckelmann D, Wolter M, Neubauer K, et al. Hermansky-Pudlak syndrome: identification of novel variants in the genes HPS3, HPS5, and DTNBP1 (HPS-7). Front Pharmacol. 2022;12:786937. Published January 19, 2022. doi:10.3389/fphar.2021.786937.
Bowman SL, Bi-Karchin J, Le L, Marks MS. The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases. Traffic. 2019;20(6):404-435. doi:10.1111/tra.12646.
Morice-Picard F, Taïeb C, Marti A, Gliksohn A, Bennani M, Bodemer C, Ezzedine K; Filière maladies rares en dermatologie: FIMARAD. Burden of albinism: development and validation of a burden assessment tool. Orphanet Journal of Rare Diseases. 2018;13(1):162.
Wu XL, Zhao XQ, Zhang BX, Xuan F, Guo HM, Ma FT. A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase. Braz J Med Biol Res. 2017;50(4):e5727. Published March 23, 2017. doi:10.1590/1414-431X20165727.